Concepedia

Laura A. Sass

LA

Statistics

Publications

8

Citations

1.3K

H-Index

8

Active since

1979

Affiliations

Eastern Virginia Medical School(Current)

Children's Hospital of The King's Daughters

Children's Specialty Group

Vertex Pharmaceuticals (United States)

Laura A. Sass is an author at Eastern Virginia Medical School specializing in cystic fibrosis, immunology, and medicine.

Publications per year

1979–2018

8

Publications

8

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

D. Keating, Gautham Marigowda, Lucy Burr et al. · New England Journal of Medicine · 2018 · 727 citations · Full text

, , +13

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 295 citations

, , +12

Histologic and ultrastructural features of the clara cell adenoma of the mouse lung.

Shirley L. Kauffman, Leslie Alexander, Laura A. Sass · PubMed · 1979 · 146 citations

, , +14

Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity

Pamela S. Hair, Laura A. Sass, Turaj Vazifedan et al. · PLoS ONE · 2017 · 32 citations · Full text

, , +17

Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)

Pamela S. Hair, Laura A. Sass, Neel K. Krishna et al. · PLoS ONE · 2017 · 21 citations · Full text

, , +15

1–5 of 8